| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 4.18e-10 | 151 | 79 | 10 | GO:0015085 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 PLP2 ANO3 SLC45A4 | 1.41e-09 | 793 | 79 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 ANO3 SLC45A4 | 5.21e-09 | 758 | 79 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 SLC45A4 | 2.02e-08 | 627 | 79 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A SLC22A15 OTOP2 SLC19A3 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 PLP2 ANO3 SLC45A4 | 2.15e-08 | 1180 | 79 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 SLC45A4 | 4.30e-08 | 664 | 79 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium channel activity | 4.33e-08 | 129 | 79 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | transporter activity | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A SLC22A15 OTOP2 SLC19A3 CACNA1I CACNA1H GRIN2C GRIN2D SLC45A1 SLC24A1 PLP2 ANO3 SLC45A4 | 9.24e-08 | 1289 | 79 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.20e-07 | 14 | 79 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANO9 CACNB1 CACNB4 TRPM5 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 ANO3 | 2.40e-07 | 459 | 79 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 2.75e-07 | 465 | 79 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNB1 CACNB4 TRPM5 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 9.89e-07 | 343 | 79 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | channel activity | ANO9 CACNB1 CACNB4 TRPM5 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 ANO3 | 9.94e-07 | 525 | 79 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANO9 CACNB1 CACNB4 TRPM5 SCN3A OTOP2 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 ANO3 | 1.01e-06 | 526 | 79 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.16e-06 | 171 | 79 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | gated channel activity | 6.77e-06 | 334 | 79 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 7.01e-06 | 10 | 79 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 1.44e-05 | 78 | 79 | 5 | GO:0003724 | |
| GeneOntologyMolecularFunction | histone H2BS36 kinase activity | 1.55e-05 | 2 | 79 | 2 | GO:0140823 | |
| GeneOntologyMolecularFunction | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity | 1.55e-05 | 2 | 79 | 2 | GO:0047322 | |
| GeneOntologyMolecularFunction | histone H2B kinase activity | 1.55e-05 | 2 | 79 | 2 | GO:0140998 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 1.63e-05 | 80 | 79 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 1.66e-05 | 13 | 79 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.26e-05 | 46 | 79 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.62e-05 | 3 | 79 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 4.62e-05 | 3 | 79 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 5.06e-05 | 431 | 79 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | sodium channel activity | 5.32e-05 | 52 | 79 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.46e-05 | 182 | 79 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.98e-05 | 184 | 79 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | sucrose:monoatomic cation symporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0009669 | |
| GeneOntologyMolecularFunction | ornithine decarboxylase activity | 9.23e-05 | 4 | 79 | 2 | GO:0004586 | |
| GeneOntologyMolecularFunction | sucrose transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0008515 | |
| GeneOntologyMolecularFunction | sucrose:proton symporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0008506 | |
| GeneOntologyMolecularFunction | oligosaccharide transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0015157 | |
| GeneOntologyMolecularFunction | disaccharide transmembrane transporter activity | 9.23e-05 | 4 | 79 | 2 | GO:0015154 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.45e-04 | 26 | 79 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.47e-04 | 31 | 79 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.43e-04 | 152 | 79 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | helicase activity | 4.09e-04 | 158 | 79 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 4.26e-04 | 8 | 79 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 4.26e-04 | 8 | 79 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 4.26e-04 | 8 | 79 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.56e-04 | 43 | 79 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 6.81e-04 | 10 | 79 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.01e-03 | 193 | 79 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.11e-03 | 197 | 79 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 2.02e-03 | 17 | 79 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.02e-03 | 17 | 79 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | myosin V binding | 2.80e-03 | 20 | 79 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 2.80e-03 | 20 | 79 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 2.80e-03 | 20 | 79 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.70e-03 | 23 | 79 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 4.03e-03 | 24 | 79 | 2 | GO:0030742 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 4.37e-03 | 25 | 79 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.09e-03 | 27 | 79 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | histone kinase activity | 5.47e-03 | 28 | 79 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 6.17e-03 | 417 | 79 | 6 | GO:0140098 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.39e-03 | 296 | 79 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1M1 OR4M2 OR51F2 OR4M1 OR2C3 OR13G1 OR5M3 GRIN2C GRIN2D PLXNA1 OR4M2B OR52J3 | 6.69e-03 | 1353 | 79 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 6.84e-03 | 301 | 79 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 7.54e-03 | 33 | 79 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 8.06e-03 | 884 | 79 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 8.92e-03 | 36 | 79 | 2 | GO:0016831 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 2.88e-07 | 392 | 79 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 PLP2 ANO3 | 8.45e-07 | 1115 | 79 | 17 | GO:0034220 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.09e-06 | 48 | 79 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.09e-06 | 48 | 79 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 ANO3 | 1.25e-06 | 1017 | 79 | 16 | GO:0098660 |
| GeneOntologyBiologicalProcess | negative regulation of tubulin deacetylation | 1.87e-06 | 7 | 79 | 3 | GO:1904428 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ANO9 CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A SLC22A15 OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 PLP2 ANO3 | 3.33e-06 | 1374 | 79 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1M1 OR4M2 OR51F2 CACNB4 NOD1 OR4M1 OR2C3 OR13G1 OR5M3 GRIN2D ANO3 OR4M2B OR52J3 | 3.34e-06 | 722 | 79 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 3.69e-06 | 509 | 79 | 11 | GO:0006816 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 9.54e-06 | 922 | 79 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | sensory perception | OR1M1 OR4M2 OR51F2 CACNB4 MYO9A OR4M1 OR2C3 OR13G1 FBXO11 OR5M3 GRIN2D SLC24A1 RAB3A OR4M2B OR52J3 | 1.16e-05 | 1072 | 79 | 15 | GO:0007600 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 1.21e-05 | 942 | 79 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1M1 OR4M2 OR51F2 CACNB4 OR4M1 OR2C3 OR13G1 OR5M3 GRIN2D OR4M2B OR52J3 | 1.31e-05 | 582 | 79 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.50e-05 | 208 | 79 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.76e-05 | 142 | 79 | 6 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.76e-05 | 142 | 79 | 6 | GO:0098659 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 1.91e-05 | 144 | 79 | 6 | GO:0060291 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.98e-05 | 217 | 79 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.73e-05 | 98 | 79 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 4.02e-05 | 432 | 79 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 7.08e-05 | 465 | 79 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | regulation of tubulin deacetylation | 7.90e-05 | 22 | 79 | 3 | GO:0090043 | |
| GeneOntologyBiologicalProcess | putrescine biosynthetic process from ornithine | 8.65e-05 | 4 | 79 | 2 | GO:0033387 | |
| GeneOntologyBiologicalProcess | oligosaccharide transport | 8.65e-05 | 4 | 79 | 2 | GO:0015772 | |
| GeneOntologyBiologicalProcess | sucrose transport | 8.65e-05 | 4 | 79 | 2 | GO:0015770 | |
| GeneOntologyBiologicalProcess | disaccharide transport | 8.65e-05 | 4 | 79 | 2 | GO:0015766 | |
| GeneOntologyBiologicalProcess | protein localization to lipid droplet | 8.65e-05 | 4 | 79 | 2 | GO:1990044 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.87e-05 | 275 | 79 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 9.76e-05 | 485 | 79 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 1.02e-04 | 1000 | 79 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | tubulin deacetylation | 1.03e-04 | 24 | 79 | 3 | GO:0090042 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.13e-04 | 65 | 79 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SLC39A11 SCN3A OTOP2 FBXO11 CACNA1I CACNA1H GRIN2C GRIN2D SLC24A1 | 1.14e-04 | 1157 | 79 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 1.31e-04 | 293 | 79 | 7 | GO:0048167 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 1.44e-04 | 5 | 79 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 1.44e-04 | 5 | 79 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 1.44e-04 | 5 | 79 | 2 | GO:0061591 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of terminal units involved in salivary gland branching | 1.44e-04 | 5 | 79 | 2 | GO:0060666 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 1.75e-04 | 524 | 79 | 9 | GO:0009593 | |
| GeneOntologyBiologicalProcess | putrescine biosynthetic process | 2.15e-04 | 6 | 79 | 2 | GO:0009446 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 2.40e-04 | 547 | 79 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.54e-04 | 230 | 79 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 2.72e-04 | 233 | 79 | 6 | GO:0050806 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | ADCY10 SLC8A2 CACNB4 SLC8A3 SCN3A CACNA1I CACNA1H GRIN2C GRIN2D | 2.82e-04 | 559 | 79 | 9 | GO:0042391 |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 2.91e-04 | 83 | 79 | 4 | GO:0048168 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 2.97e-04 | 34 | 79 | 3 | GO:0090311 | |
| GeneOntologyBiologicalProcess | lipid droplet disassembly | 3.00e-04 | 7 | 79 | 2 | GO:1905691 | |
| GeneOntologyBiologicalProcess | positive regulation of response to food | 3.00e-04 | 7 | 79 | 2 | GO:0032097 | |
| GeneOntologyBiologicalProcess | positive regulation of appetite | 3.00e-04 | 7 | 79 | 2 | GO:0032100 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-lysine acetylation | 3.00e-04 | 7 | 79 | 2 | GO:2000758 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.52e-04 | 36 | 79 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | positive regulation of response to nutrient levels | 4.00e-04 | 8 | 79 | 2 | GO:0032109 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte apoptotic process | 4.00e-04 | 8 | 79 | 2 | GO:1903944 | |
| GeneOntologyBiologicalProcess | putrescine metabolic process | 5.12e-04 | 9 | 79 | 2 | GO:0009445 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 5.57e-04 | 42 | 79 | 3 | GO:0060402 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 6.83e-04 | 45 | 79 | 3 | GO:0017158 | |
| GeneOntologyBiologicalProcess | acrosome reaction | 7.77e-04 | 47 | 79 | 3 | GO:0007340 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 7.77e-04 | 47 | 79 | 3 | GO:0006476 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of an epithelial terminal unit | 7.79e-04 | 11 | 79 | 2 | GO:0060600 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte apoptotic process | 7.79e-04 | 11 | 79 | 2 | GO:1903943 | |
| GeneOntologyBiologicalProcess | positive regulation of ATP metabolic process | 8.26e-04 | 48 | 79 | 3 | GO:1903580 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 9.05e-04 | 112 | 79 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of stress granule assembly | 9.32e-04 | 12 | 79 | 2 | GO:0062028 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 9.32e-04 | 12 | 79 | 2 | GO:1990034 | |
| GeneOntologyBiologicalProcess | ornithine metabolic process | 9.32e-04 | 12 | 79 | 2 | GO:0006591 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-lysine acetylation | 9.32e-04 | 12 | 79 | 2 | GO:2000756 | |
| GeneOntologyBiologicalProcess | negative regulation of TORC1 signaling | 1.04e-03 | 52 | 79 | 3 | GO:1904262 | |
| GeneOntologyBiologicalProcess | action potential | 1.05e-03 | 201 | 79 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.21e-03 | 121 | 79 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide metabolic process | 1.23e-03 | 55 | 79 | 3 | GO:0045981 | |
| GeneOntologyBiologicalProcess | positive regulation of purine nucleotide metabolic process | 1.23e-03 | 55 | 79 | 3 | GO:1900544 | |
| GeneOntologyBiologicalProcess | protein deacylation | 1.43e-03 | 58 | 79 | 3 | GO:0035601 | |
| GeneOntologyBiologicalProcess | polyamine biosynthetic process | 1.47e-03 | 15 | 79 | 2 | GO:0006596 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.57e-03 | 130 | 79 | 4 | GO:0060079 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin E stimulus | 1.68e-03 | 16 | 79 | 2 | GO:0071380 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 1.68e-03 | 16 | 79 | 2 | GO:0098976 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 1.82e-03 | 63 | 79 | 3 | GO:0098732 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.82e-03 | 63 | 79 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 2.01e-03 | 233 | 79 | 5 | GO:0017157 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 2.08e-03 | 66 | 79 | 3 | GO:1903307 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium-dependent cell motility | 2.13e-03 | 18 | 79 | 2 | GO:2000155 | |
| GeneOntologyBiologicalProcess | positive regulation of flagellated sperm motility | 2.13e-03 | 18 | 79 | 2 | GO:1902093 | |
| GeneOntologyBiologicalProcess | positive regulation of protein acetylation | 2.13e-03 | 18 | 79 | 2 | GO:1901985 | |
| GeneOntologyBiologicalProcess | fatty acid homeostasis | 2.13e-03 | 18 | 79 | 2 | GO:0055089 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.73e-05 | 46 | 79 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.40e-05 | 17 | 79 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.05e-05 | 378 | 79 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.69e-04 | 73 | 79 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.77e-04 | 29 | 79 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 4.99e-04 | 9 | 79 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | nucleotide-activated protein kinase complex | 7.59e-04 | 11 | 79 | 2 | GO:0031588 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 8.00e-04 | 523 | 79 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.11e-03 | 550 | 79 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | neuronal cell body | ADCY10 SLC8A2 SLC8A3 TRPM5 AZIN2 SCN3A PRKAA1 PRKAA2 CACNA1H SLC24A1 | 1.17e-03 | 835 | 79 | 10 | GO:0043025 |
| GeneOntologyCellularComponent | axon | ADCY10 SLC8A2 SLC8A3 MYO9A AZIN2 SCN3A PRKAA1 PRKAA2 CBL RAB3A | 1.89e-03 | 891 | 79 | 10 | GO:0030424 |
| GeneOntologyCellularComponent | cation channel complex | 1.97e-03 | 235 | 79 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | cell body | ADCY10 SLC8A2 SLC8A3 TRPM5 AZIN2 SCN3A PRKAA1 PRKAA2 CACNA1H SLC24A1 | 2.56e-03 | 929 | 79 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.79e-03 | 785 | 79 | 9 | GO:0098797 | |
| Domain | NaCa_Exmemb | 5.56e-06 | 9 | 77 | 3 | IPR004837 | |
| Domain | Na_Ca_ex | 5.56e-06 | 9 | 77 | 3 | PF01699 | |
| Domain | AMPK_C | 1.68e-05 | 2 | 77 | 2 | IPR032270 | |
| Domain | De-COase2_pyr-phos_BS | 1.68e-05 | 2 | 77 | 2 | IPR022653 | |
| Domain | AdenylateSensor | 1.68e-05 | 2 | 77 | 2 | PF16579 | |
| Domain | P-loop_NTPase | ADCY10 CACNB1 CACNB4 NOD1 DDX17 MYO9A MOV10L1 DDX42 BMS1 DDX3Y RAB3A RAB3B SNRNP200 | 3.95e-05 | 848 | 77 | 13 | IPR027417 |
| Domain | Orn_de-COase | 5.02e-05 | 3 | 77 | 2 | IPR002433 | |
| Domain | - | 5.02e-05 | 3 | 77 | 2 | 2.40.37.10 | |
| Domain | Na_Ca_Ex | 5.02e-05 | 3 | 77 | 2 | IPR004836 | |
| Domain | Ala_racemase/Decarboxylase_C | 5.02e-05 | 3 | 77 | 2 | IPR009006 | |
| Domain | Orn_Arg_deC_N | 5.02e-05 | 3 | 77 | 2 | PF02784 | |
| Domain | Na_Ca_Ex_C-exten | 5.02e-05 | 3 | 77 | 2 | IPR032452 | |
| Domain | De-COase2_CS | 5.02e-05 | 3 | 77 | 2 | IPR022657 | |
| Domain | De-COase2_N | 5.02e-05 | 3 | 77 | 2 | IPR022644 | |
| Domain | De-COase2_C | 5.02e-05 | 3 | 77 | 2 | IPR022643 | |
| Domain | ODR_DC_2_1 | 5.02e-05 | 3 | 77 | 2 | PS00878 | |
| Domain | ODR_DC_2_2 | 5.02e-05 | 3 | 77 | 2 | PS00879 | |
| Domain | Orn_DAP_Arg_deC | 5.02e-05 | 3 | 77 | 2 | PF00278 | |
| Domain | VDCC_T_a1 | 5.02e-05 | 3 | 77 | 2 | IPR005445 | |
| Domain | Na_Ca_ex_C | 5.02e-05 | 3 | 77 | 2 | PF16494 | |
| Domain | Orn/DAP/Arg_de-COase | 5.02e-05 | 3 | 77 | 2 | IPR000183 | |
| Domain | - | ADCY10 CACNB1 CACNB4 NOD1 DDX17 MOV10L1 DDX42 BMS1 DDX3Y RAB3A RAB3B SNRNP200 | 5.11e-05 | 746 | 77 | 12 | 3.40.50.300 |
| Domain | VDCC_L_bsu | 1.00e-04 | 4 | 77 | 2 | IPR000584 | |
| Domain | - | 1.00e-04 | 4 | 77 | 2 | 3.20.20.10 | |
| Domain | PLP-binding_barrel | 1.00e-04 | 4 | 77 | 2 | IPR029066 | |
| Domain | VGCC_beta4Aa_N | 1.00e-04 | 4 | 77 | 2 | PF12052 | |
| Domain | Olfact_rcpt | 2.12e-04 | 393 | 77 | 8 | IPR000725 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.34e-04 | 73 | 77 | 4 | IPR011545 | |
| Domain | DEAD | 2.34e-04 | 73 | 77 | 4 | PF00270 | |
| Domain | DEAD_ATP_HELICASE | 2.79e-04 | 31 | 77 | 3 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 3.36e-04 | 33 | 77 | 3 | IPR000629 | |
| Domain | KA1/Ssp2_C | 3.48e-04 | 7 | 77 | 2 | IPR028375 | |
| Domain | TPR-like_helical_dom | 4.00e-04 | 233 | 77 | 6 | IPR011990 | |
| Domain | Calx_beta | 4.62e-04 | 8 | 77 | 2 | SM00237 | |
| Domain | Q_MOTIF | 4.73e-04 | 37 | 77 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 4.73e-04 | 37 | 77 | 3 | IPR014014 | |
| Domain | Calx_beta | 5.93e-04 | 9 | 77 | 2 | IPR003644 | |
| Domain | Calx-beta | 5.93e-04 | 9 | 77 | 2 | PF03160 | |
| Domain | Anoctamin | 7.39e-04 | 10 | 77 | 2 | PF04547 | |
| Domain | Anoctamin | 7.39e-04 | 10 | 77 | 2 | IPR007632 | |
| Domain | VDCCAlpha1 | 7.39e-04 | 10 | 77 | 2 | IPR002077 | |
| Domain | Helicase_C | 9.99e-04 | 107 | 77 | 4 | PF00271 | |
| Domain | HELICc | 9.99e-04 | 107 | 77 | 4 | SM00490 | |
| Domain | Helicase_C | 1.03e-03 | 108 | 77 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.07e-03 | 109 | 77 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.07e-03 | 109 | 77 | 4 | PS51192 | |
| Domain | DEXDc | 1.07e-03 | 109 | 77 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.11e-03 | 110 | 77 | 4 | IPR014001 | |
| Domain | Ion_trans_dom | 1.26e-03 | 114 | 77 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.26e-03 | 114 | 77 | 4 | PF00520 | |
| Domain | - | 1.65e-03 | 207 | 77 | 5 | 1.25.40.10 | |
| Domain | Channel_four-helix_dom | 1.68e-03 | 57 | 77 | 3 | IPR027359 | |
| Domain | - | 1.68e-03 | 57 | 77 | 3 | 1.20.120.350 | |
| Domain | Iontro_rcpt | 2.46e-03 | 18 | 77 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.46e-03 | 18 | 77 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 2.46e-03 | 18 | 77 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.46e-03 | 18 | 77 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.46e-03 | 18 | 77 | 2 | SM00918 | |
| Domain | Lig_chan | 2.46e-03 | 18 | 77 | 2 | PF00060 | |
| Domain | PBPe | 2.46e-03 | 18 | 77 | 2 | SM00079 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 3.47e-06 | 50 | 66 | 5 | M39822 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.15e-06 | 25 | 66 | 4 | M47948 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.57e-05 | 11 | 66 | 3 | M27336 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.71e-05 | 13 | 66 | 3 | MM15078 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1M1 OR4M2 OR51F2 TRPM5 SCN3A OR4M1 OR2C3 OR13G1 OR5M3 SLC24A1 RAB3A OR52J3 | 3.37e-05 | 636 | 66 | 12 | M41834 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.29e-05 | 42 | 66 | 4 | M7169 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.81e-04 | 178 | 66 | 6 | M2890 | |
| Pathway | WP_THYROXINE_THYROID_HORMONE_PRODUCTION | 2.09e-04 | 25 | 66 | 3 | M39353 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.12e-04 | 63 | 66 | 4 | M11187 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 2.14e-04 | 5 | 66 | 2 | M47667 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.14e-04 | 5 | 66 | 2 | MM15655 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.60e-04 | 270 | 66 | 7 | M15514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 3.20e-04 | 6 | 66 | 2 | M47668 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.67e-04 | 203 | 66 | 6 | M5485 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 4.44e-04 | 389 | 66 | 8 | M14091 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY | 5.94e-04 | 8 | 66 | 2 | M47916 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 6.10e-04 | 83 | 66 | 4 | M8728 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 7.01e-04 | 417 | 66 | 8 | M4072 | |
| Pathway | REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION | 9.48e-04 | 10 | 66 | 2 | M27146 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 9.74e-04 | 94 | 66 | 4 | M2843 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.16e-03 | 11 | 66 | 2 | MM14498 | |
| Pathway | BIOCARTA_LEPTIN_PATHWAY | 1.16e-03 | 11 | 66 | 2 | M18053 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.16e-03 | 11 | 66 | 2 | M26913 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.38e-03 | 12 | 66 | 2 | M27326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 1.38e-03 | 12 | 66 | 2 | M47953 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 1.63e-03 | 13 | 66 | 2 | M46426 | |
| Pathway | WP_THERMOGENESIS | 1.63e-03 | 108 | 66 | 4 | M39746 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.52e-08 | 38 | 79 | 5 | 30786075 | |
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 2.24e-07 | 6 | 79 | 3 | 17311327 | |
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 3.92e-07 | 7 | 79 | 3 | 33542309 | |
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 18809727 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.90e-06 | 89 | 79 | 5 | 22446626 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23137542 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21673972 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18801964 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21947382 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32839348 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20465544 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 5.09e-06 | 2 | 79 | 2 | 12808460 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29651654 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17324122 | ||
| Pubmed | Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. | 5.09e-06 | 2 | 79 | 2 | 19236843 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23905686 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31110197 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24420540 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33931447 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19832840 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32504885 | ||
| Pubmed | Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK. | 5.09e-06 | 2 | 79 | 2 | 38657612 | |
| Pubmed | Coordinated maintenance of muscle cell size control by AMP-activated protein kinase. | 5.09e-06 | 2 | 79 | 2 | 20460585 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31540695 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25071191 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27600021 | ||
| Pubmed | Compound C inhibits hypoxic activation of HIF-1 independent of AMPK. | 5.09e-06 | 2 | 79 | 2 | 18036344 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23486478 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 30217073 | ||
| Pubmed | Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. | 5.09e-06 | 2 | 79 | 2 | 15878932 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24228806 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21506122 | ||
| Pubmed | AMPK activation regulates neuronal structure in developing hippocampal neurons. | 5.09e-06 | 2 | 79 | 2 | 24295634 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27052588 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25767884 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18350549 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 36786913 | ||
| Pubmed | Loss of AMPK activity induces organelle dysfunction and oxidative stress during oocyte aging. | 5.09e-06 | 2 | 79 | 2 | 38654312 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22763120 | ||
| Pubmed | Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. | 5.09e-06 | 2 | 79 | 2 | 17446219 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24403081 | ||
| Pubmed | AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. | 5.09e-06 | 2 | 79 | 2 | 22233421 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 14573616 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 35057644 | ||
| Pubmed | Ca2+ regulation in the Na+/Ca2+ exchanger features a dual electrostatic switch mechanism. | 5.09e-06 | 2 | 79 | 2 | 19667209 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26843621 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21209024 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24855056 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26419588 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23527250 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28974562 | ||
| Pubmed | Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. | 5.09e-06 | 2 | 79 | 2 | 12546688 | |
| Pubmed | Polarized activities of AMPK and BRSK in primary hippocampal neurons. | 5.09e-06 | 2 | 79 | 2 | 25788287 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12788940 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 38019084 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 14500989 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31786200 | ||
| Pubmed | The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma. | 5.09e-06 | 2 | 79 | 2 | 34347929 | |
| Pubmed | Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. | 5.09e-06 | 2 | 79 | 2 | 29610348 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19268526 | ||
| Pubmed | Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK. | 5.09e-06 | 2 | 79 | 2 | 31693892 | |
| Pubmed | Metabolic regulation of neuronal plasticity by the energy sensor AMPK. | 5.09e-06 | 2 | 79 | 2 | 20126541 | |
| Pubmed | Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice. | 5.09e-06 | 2 | 79 | 2 | 32213711 | |
| Pubmed | AMPK knockdown in placental trophoblast cells results in altered morphology and function. | 5.09e-06 | 2 | 79 | 2 | 25003940 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29928235 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 36028487 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 25609422 | ||
| Pubmed | [AMPK as a Metabolic Intersection between Diet and Physical Exercise]. | 5.09e-06 | 2 | 79 | 2 | 30270274 | |
| Pubmed | AMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability. | 5.09e-06 | 2 | 79 | 2 | 20558612 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23306156 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28225087 | ||
| Pubmed | AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. | 5.09e-06 | 2 | 79 | 2 | 21483791 | |
| Pubmed | AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. | 5.09e-06 | 2 | 79 | 2 | 20399918 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34767944 | ||
| Pubmed | Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice. | 5.09e-06 | 2 | 79 | 2 | 26244519 | |
| Pubmed | Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. | 5.09e-06 | 2 | 79 | 2 | 18701654 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 12091379 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24665903 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20830737 | ||
| Pubmed | AMPKalpha1 deletion shortens erythrocyte life span in mice: role of oxidative stress. | 5.09e-06 | 2 | 79 | 2 | 20392689 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29317596 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22119190 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29515462 | ||
| Pubmed | Protein expression alteration in hippocampus upon genetic repression of AMPKα isoforms. | 5.09e-06 | 2 | 79 | 2 | 33492732 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29038293 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21432774 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32184359 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18195011 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16186119 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26268732 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21993711 | ||
| Pubmed | Kidney-specific genetic deletion of both AMPK α-subunits causes salt and water wasting. | 5.09e-06 | 2 | 79 | 2 | 28179232 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16916800 | ||
| Pubmed | The role of the mitochondrial NCX in the mechanism of neurodegeneration in Parkinson's disease. | 5.09e-06 | 2 | 79 | 2 | 23224884 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33766086 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16567505 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27879319 | ||
| Pubmed | Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. | 5.09e-06 | 2 | 79 | 2 | 19486896 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 28107516 | ||
| Pubmed | AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity. | 5.09e-06 | 2 | 79 | 2 | 24652947 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.01e-06 | 26 | 54 | 4 | 253 | |
| GeneFamily | Solute carriers | SLC8A2 SLC8A3 SLC39A11 SLC22A15 SLC19A3 SLC45A1 SLC24A1 SLC45A4 | 2.09e-05 | 395 | 54 | 8 | 752 |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.82e-04 | 7 | 54 | 2 | 1201 | |
| GeneFamily | DEAD-box helicases | 2.66e-04 | 42 | 54 | 3 | 499 | |
| GeneFamily | Anoctamins | 3.88e-04 | 10 | 54 | 2 | 865 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.72e-03 | 26 | 54 | 2 | 904 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.02e-02 | 51 | 54 | 2 | 870 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-05 | 177 | 78 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-05 | 182 | 78 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-05 | 182 | 78 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 183 | 78 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 184 | 78 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 184 | 78 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.43e-05 | 196 | 78 | 5 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.55e-05 | 198 | 78 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| Computational | Neighborhood of DDB1 | 4.81e-05 | 246 | 43 | 7 | MORF_DDB1 | |
| Computational | Neighborhood of PRKAG1 | 2.45e-04 | 224 | 43 | 6 | MORF_PRKAG1 | |
| Drug | bepridil | 1.07e-08 | 126 | 77 | 8 | CID000002351 | |
| Drug | Mibefradil | 3.92e-08 | 11 | 77 | 4 | DB01388 | |
| Drug | lamotrigine | 1.33e-07 | 116 | 77 | 7 | CID000003878 | |
| Drug | Dantrolene-13C3 | 6.09e-07 | 145 | 77 | 7 | CID000002951 | |
| Drug | loperamide | 1.51e-06 | 105 | 77 | 6 | CID000003954 | |
| Drug | gabapentin | 1.70e-06 | 169 | 77 | 7 | CID000003446 | |
| Drug | ES-242-1 | 2.06e-06 | 8 | 77 | 3 | CID000131976 | |
| Drug | riluzole | 2.07e-06 | 174 | 77 | 7 | CID000005070 | |
| Drug | NSC7524 | 2.79e-06 | 182 | 77 | 7 | CID000005657 | |
| Drug | Landel | 3.08e-06 | 9 | 77 | 3 | CID000163838 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ADCY10 CACNB1 CACNB4 MAPK12 CACNA1I CACNA1H GRIN2C ODC1 GRIN2D SLC24A1 PGC | 3.70e-06 | 577 | 77 | 11 | CID000000295 |
| Drug | baclofen | 3.84e-06 | 191 | 77 | 7 | CID000002284 | |
| Drug | CNS 1145 | 4.59e-06 | 33 | 77 | 4 | CID000190902 | |
| Drug | IHC-64 | 4.59e-06 | 33 | 77 | 4 | CID000162753 | |
| Drug | lanthanum | 6.81e-06 | 136 | 77 | 6 | CID000023926 | |
| Drug | nimodipine | 9.83e-06 | 145 | 77 | 6 | CID000004497 | |
| Drug | BLX 1002 | 1.13e-05 | 2 | 77 | 2 | ctd:C542815 | |
| Drug | N-methyl-DL-aspartic acid | CACNB1 CACNB4 GNPTAB CACNA1I CACNA1H NUP214 GRIN2C GRIN2D SLC24A1 CABIN1 RAB3A | 1.22e-05 | 655 | 77 | 11 | CID000004376 |
| Drug | manidipine | 1.77e-05 | 95 | 77 | 5 | CID000004008 | |
| Drug | Verapamil | 2.02e-05 | 16 | 77 | 3 | DB00661 | |
| Drug | isradipine | 2.27e-05 | 100 | 77 | 5 | CID000003784 | |
| Drug | Zonisamide | 2.44e-05 | 17 | 77 | 3 | DB00909 | |
| Drug | cyclothiazide | 2.62e-05 | 103 | 77 | 5 | CID000002910 | |
| Drug | potassium | CACNB1 SLC8A2 CACNB4 SLC8A3 TRPM5 SCN3A CACNA1I CACNA1H GRIN2C ODC1 GRIN2D SLC24A1 RAB3A | 3.07e-05 | 1008 | 77 | 13 | CID000000813 |
| Drug | SureCN2398996 | 3.38e-05 | 3 | 77 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 3.38e-05 | 3 | 77 | 2 | CID000092154 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 3.38e-05 | 3 | 77 | 2 | CID010679219 | |
| Drug | Cinildipine | 3.89e-05 | 56 | 77 | 4 | CID000002752 | |
| Drug | Nimesulide [51803-78-2]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.94e-05 | 193 | 77 | 6 | 2275_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 4.94e-05 | 193 | 77 | 6 | 5268_UP | |
| Drug | nilvadipine | 5.11e-05 | 60 | 77 | 4 | CID000004494 | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 2278_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 4384_DN | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 2796_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 3315_UP | |
| Drug | IAA-94 | 5.45e-05 | 61 | 77 | 4 | CID000003667 | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; HL60; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 2543_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 6053_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; PC3; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 5045_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 6007_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 77 | 6 | 7429_UP | |
| Drug | colchicine; Down 200; 0.1uM; MCF7; HG-U133A | 5.85e-05 | 199 | 77 | 6 | 644_DN | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 6.02e-05 | 200 | 77 | 6 | 2788_UP | |
| Drug | lercanidipine | 6.19e-05 | 63 | 77 | 4 | CID000065866 | |
| Drug | YM90K | 6.27e-05 | 23 | 77 | 3 | CID005486547 | |
| Drug | methsuximide | 6.74e-05 | 4 | 77 | 2 | CID000006476 | |
| Drug | N,N'-bis(3-aminopropyl)cadaverine | 6.74e-05 | 4 | 77 | 2 | CID003080781 | |
| Drug | enzacamene | 7.70e-05 | 129 | 77 | 5 | ctd:C038939 | |
| Drug | gallopamil | 7.88e-05 | 67 | 77 | 4 | CID000001234 | |
| Drug | nifedipine | 7.99e-05 | 415 | 77 | 8 | CID000004485 | |
| Drug | glutamate | CACNB1 CACNB4 TRPM5 MAPK12 AZIN2 CACNA1I CACNA1H GRIN2C ODC1 GRIN2D CABIN1 RAB3A | 8.82e-05 | 962 | 77 | 12 | CID000000611 |
| Drug | AC1L2AC7 | 8.85e-05 | 69 | 77 | 4 | CID000068733 | |
| Drug | amiloride | 9.53e-05 | 315 | 77 | 7 | CID000016230 | |
| Drug | octylmethoxycinnamate | 1.10e-04 | 139 | 77 | 5 | ctd:C118580 | |
| Drug | CAS 298-57-7 | 1.10e-04 | 73 | 77 | 4 | CID000002761 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 1.12e-04 | 5 | 77 | 2 | ctd:C498554 | |
| Drug | AC1O7G5C | 1.12e-04 | 5 | 77 | 2 | CID006603942 | |
| Drug | 2-Aminoadipic Acid | 1.12e-04 | 5 | 77 | 2 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 1.12e-04 | 5 | 77 | 2 | ctd:C491996 | |
| Drug | phensuximide | 1.12e-04 | 5 | 77 | 2 | CID000006839 | |
| Drug | Flunarizine | 1.12e-04 | 5 | 77 | 2 | DB04841 | |
| Drug | SDZ EAA 494 | 1.12e-04 | 5 | 77 | 2 | ctd:C065286 | |
| Drug | ethosuximide | 1.16e-04 | 74 | 77 | 4 | CID000003291 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNB1 CACNB4 SLC8A3 MAPK12 CACNA1I CACNA1H CABIN1 RAB3A RAB3B | 1.25e-04 | 568 | 77 | 9 | CID000000806 |
| Drug | nicardipine | 1.34e-04 | 145 | 77 | 5 | CID000004473 | |
| Drug | AC1L32TU | 1.41e-04 | 30 | 77 | 3 | CID000107831 | |
| Drug | nisoldipine | 1.43e-04 | 78 | 77 | 4 | CID000004499 | |
| Drug | imipramine | 1.46e-04 | 235 | 77 | 6 | CID000003696 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.50e-04 | 79 | 77 | 4 | CID005287890 | |
| Drug | AC1MQ5W8 | 1.68e-04 | 6 | 77 | 2 | CID003396482 | |
| Drug | cerebrocrast | 1.68e-04 | 6 | 77 | 2 | CID000159556 | |
| Drug | Naphthols | 1.68e-04 | 6 | 77 | 2 | ctd:D009284 | |
| Drug | Meperidine | 1.68e-04 | 6 | 77 | 2 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 1.68e-04 | 6 | 77 | 2 | CID000004025 | |
| Drug | 3,4-dihydroquinazoline | 1.68e-04 | 6 | 77 | 2 | CID000583065 | |
| Drug | 6,8-diallyl 5,7-dihydroxy 2-(2-allyl 3-hydroxy 4-methoxyphenyl)1-H benzo(b)pyran-4-one | 1.68e-04 | 6 | 77 | 2 | ctd:C438505 | |
| Drug | procaine | 1.72e-04 | 153 | 77 | 5 | CID000004914 | |
| Drug | oriens | 1.77e-04 | 154 | 77 | 5 | CID000161645 | |
| Drug | pentamidine | 1.89e-04 | 33 | 77 | 3 | CID000004735 | |
| Drug | butylparaben | 1.94e-04 | 157 | 77 | 5 | ctd:C038091 | |
| Drug | KMBA | 2.06e-04 | 34 | 77 | 3 | CID000000473 | |
| Drug | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid | 2.25e-04 | 35 | 77 | 3 | ctd:C520612 | |
| Drug | Tenocyclidine | 2.34e-04 | 7 | 77 | 2 | DB01520 | |
| Drug | LY215840 | 2.34e-04 | 7 | 77 | 2 | CID000132049 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 2.34e-04 | 7 | 77 | 2 | ctd:C050592 | |
| Drug | tetrazol-5-yl)glycine | 2.34e-04 | 7 | 77 | 2 | CID000126383 | |
| Drug | homoquinolinate | 2.34e-04 | 7 | 77 | 2 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 2.34e-04 | 7 | 77 | 2 | CID001502069 | |
| Drug | losigamone | 2.34e-04 | 7 | 77 | 2 | CID000060572 | |
| Drug | AC1NDT8A | 2.66e-04 | 37 | 77 | 3 | CID004631218 | |
| Drug | AC1MMLID | 2.70e-04 | 92 | 77 | 4 | CID000013245 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 3.12e-04 | 8 | 77 | 2 | CID000081143 | |
| Drug | SDZ 220-581 | 3.12e-04 | 8 | 77 | 2 | CID000128019 | |
| Drug | 3alpha5betaHS | 3.12e-04 | 8 | 77 | 2 | CID000165024 | |
| Drug | neramexane | 3.12e-04 | 8 | 77 | 2 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 3.12e-04 | 8 | 77 | 2 | CID000280973 | |
| Drug | L-687,414 | 3.12e-04 | 8 | 77 | 2 | CID000125556 | |
| Drug | papaverine | 3.29e-04 | 176 | 77 | 5 | CID000004680 | |
| Drug | isotetrandrine | 3.30e-04 | 97 | 77 | 4 | CID000005422 | |
| Drug | ginsenoside Rg3 | 3.36e-04 | 40 | 77 | 3 | CID000159727 | |
| Disease | epilepsy (implicated_via_orthology) | 2.76e-06 | 163 | 71 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Ectodermal Dysplasia | 8.51e-05 | 6 | 71 | 2 | C0013575 | |
| Disease | Epilepsy, Generalized | 8.51e-05 | 6 | 71 | 2 | C0014548 | |
| Disease | Idiopathic generalized epilepsy | 8.51e-05 | 6 | 71 | 2 | cv:C0270850 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.27e-04 | 49 | 71 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | 4-acetamidobutanoate measurement | 6.70e-04 | 16 | 71 | 2 | EFO_0021003 | |
| Disease | thyroxine measurement, triiodothyronine measurement | 7.58e-04 | 17 | 71 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | Impaired glucose tolerance | 1.65e-03 | 25 | 71 | 2 | C0271650 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.83e-03 | 100 | 71 | 3 | DOID:1824 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVEYIEALELMFSMF | 251 | Q4G0S4 | |
| GYEVTDMMQKALFDF | 241 | Q02641 | |
| MVMEYVSGGELFDYI | 91 | P54646 | |
| MAGYLSESDFVMVEE | 1 | Q96A70 | |
| MDYFDGVLMFVDISG | 36 | Q96PN6 | |
| SLFDEFMEMMIQYGF | 536 | A1A5B4 | |
| MSLGIMEEEDLAEYF | 1 | Q96M95 | |
| LMLIDASFGFEMETF | 151 | Q14692 | |
| GYEVTDMMQKALFDF | 231 | O00305 | |
| GMTYNDFFMVLTDVD | 706 | Q76M96 | |
| LMDEYLEMVLQFGFT | 751 | Q9BYT9 | |
| EKEAYMGFMNSFLEE | 656 | Q86YV0 | |
| MGFILMYDITNEESF | 96 | P20336 | |
| MGFILMYDITNEESF | 96 | P20337 | |
| EMFLLTVMAFDLYTA | 111 | A0A0X1KG70 | |
| GAEMVLFTTMAYDRY | 106 | Q8NGZ3 | |
| YGMIDDMIYFSSDAV | 51 | Q9BXT6 | |
| GMMYVFVALAIVCDE | 461 | O60721 | |
| YRFEIMGEEEIAFKM | 1111 | Q3T906 | |
| RLMFTMYDLDENGFL | 861 | Q9NRD8 | |
| VSYLVFDEADRMFDM | 401 | Q86XP3 | |
| YEAFSETMLLDLFFM | 1426 | Q96RV3 | |
| LMANEEDADMFGFVY | 206 | Q9UIW2 | |
| FTFMESGVLLAMAFD | 121 | Q8NH61 | |
| FVGASEMFLLTVMAY | 106 | Q8NGD0 | |
| EMFLLTVMAFDLYTA | 111 | Q8NGB6 | |
| YDFALDKIGMEIMSY | 126 | Q12996 | |
| MLMSFLVDDYTFNVD | 376 | Q8WX92 | |
| EEIYMDTIMELVGFS | 156 | Q9Y239 | |
| MMSSEYGSIIAFFDV | 111 | P35658 | |
| GEMVMLYDLFFAFLQ | 886 | P42704 | |
| NEMEMYLASFVFVVL | 196 | Q8N628 | |
| FILAAMAFDRYMAIG | 111 | Q8NGP4 | |
| EMILAAIFFVVYMCD | 56 | Q04941 | |
| AVYDTDVFALLTAMM | 56 | Q7RTS6 | |
| VLTAYLDYMEELGML | 391 | P0DPD8 | |
| LETAMEFYLEAVMLD | 106 | Q9Y6J0 | |
| VFMEGSEDAYVGYMT | 331 | Q86XK2 | |
| NRLDFFIVMAGMVEY | 151 | Q9P0X4 | |
| VLMYASFGFVDLEEM | 176 | A6NJJ6 | |
| METLGENEYFRVFME | 106 | P22681 | |
| YLVLDEADRMLDMGF | 321 | Q92841 | |
| LMESDFEFEYLMALR | 2051 | Q5TBA9 | |
| YLVLDEADRMLDMGF | 341 | O15523 | |
| YDNELMDMRGIFLAF | 356 | Q6UWR7 | |
| FFIVVAGMMEYSLDG | 176 | O95180 | |
| SYEFFAVTRFLVGMM | 161 | Q8IZD6 | |
| MQVVEFFYGMVTAAE | 106 | Q9BZV2 | |
| AFAAGAMVYVVMDDI | 296 | Q8N1S5 | |
| FEGMLLFYTDFMGEV | 571 | Q9Y2W3 | |
| DISDTLMYVYEMLGA | 426 | O94829 | |
| RCVFDMGAEVGFSMY | 216 | P11926 | |
| PVVARMIYEMFSGDF | 396 | O14896 | |
| FFGIVDSVIIAMMAY | 106 | Q8NGA1 | |
| DSVIIAMMAYDRFVA | 111 | Q8NGA1 | |
| GMEAEVLLAMAFDRY | 111 | Q8NH60 | |
| DGLDGETIFMYMFLA | 201 | P43307 | |
| EELFSGMYIDFMGTD | 181 | Q99985 | |
| GMYIDFMGTDAAIFR | 186 | Q99985 | |
| FVMVLTAEGDMAYLS | 96 | Q9Y2N7 | |
| IVGMFLAEMIEKYFV | 1601 | Q9NY46 | |
| DMARFYLAEMVIAID | 176 | Q5VT25 | |
| RFFVMYADGSGMELL | 1641 | Q6Q759 | |
| FMVMEYVSGGELFDY | 101 | Q13131 | |
| GAVMFGREFCYAMET | 56 | Q5BKX6 | |
| VVTAEAFAALIDMMY | 71 | O15062 | |
| LEYEGNVEDDMMITF | 666 | Q05086 | |
| FEAGRTVLAMDFMVF | 831 | Q9NZQ8 | |
| MAYMDAAYFGEISIG | 66 | P20142 | |
| EMMVAIFEYIDRLFS | 76 | Q9H0D6 | |
| HFMIYEETSGMLLFL | 421 | Q9UK55 | |
| KLEGFALMADMVYVT | 1071 | O75643 | |
| EYFMVQEELAFVFEM | 221 | P48553 | |
| VDMDVYDAFSILDML | 386 | Q9NYU1 | |
| EMTAEFYALKGMFLA | 3116 | Q9Y4A5 | |
| DFTDFYLVMPFMGTD | 101 | P53778 | |
| YMFLGVSIIADRFMA | 81 | Q9UPR5 | |
| YMFLGVSIIADRFMA | 86 | P57103 | |
| MTFELYEEFLRAMGL | 2146 | B2RTY4 | |
| DIDNMAGVFYMLLVA | 811 | Q14957 | |
| DIDNMAGVFYMLLVA | 841 | O15399 |